
Cannabis based medicines group GW Pharmaceuticals has had its Sativex treatment for the relief of spasticity in Multiple Sclerosis (MS) approved by the New Zealand regulatory authority.
The mouth spray, which contains two cannabinoids or active ingredients - THC and CBD - is the first cannabinoid medicine derived from whole plant extracts from the cannabis sativa plant...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... geid/1814/